Skip to main content

Illumina CEO touts Grail’s 100% revenue growth amid proxy fight with Icahn

CEO Francis deSouza said San Diego-based Illumina can significantly expand the market for Grail's early cancer screening test.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.